KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Work In Process: 2009-2018

Historic Work In Process for Teva Pharmaceutical Industries (TEVA) over the last 10 years, with Dec 2018 value amounting to $590.0 million.

  • Teva Pharmaceutical Industries' Work In Process fell 1.17% to $590.0 million in Q4 2018 from the same period last year, while for Dec 2018 it was $590.0 million, marking a year-over-year decrease of 1.17%. This contributed to the annual value of $590.0 million for FY2018, which is 1.17% down from last year.
  • Per Teva Pharmaceutical Industries' latest filing, its Work In Process stood at $590.0 million for FY2018, which was down 1.17% from $597.0 million recorded in FY2017.
  • Teva Pharmaceutical Industries' Work In Process' 5-year high stood at $638.0 million during FY2014, with a 5-year trough of $535.0 million in FY2015.
  • For the 3-year period, Teva Pharmaceutical Industries' Work In Process averaged around $575.0 million, with its median value being $590.0 million (2018).
  • As far as peak fluctuations go, Teva Pharmaceutical Industries' Work In Process declined by 16.14% in 2015, and later rose by 10.97% in 2017.
  • Over the past 5 years, Teva Pharmaceutical Industries' Work In Process (Yearly) stood at $638.0 million in 2014, then decreased by 16.14% to $535.0 million in 2015, then increased by 0.56% to $538.0 million in 2016, then rose by 10.97% to $597.0 million in 2017, then fell by 1.17% to $590.0 million in 2018.